Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Child Birth
- Leukemia
- Nursing
- Pneumonia
- Preventive Medicine
- Medical Radiography
- Hepatitis
- Tuberculosis
Abstract
Citation: Clin Case Rep Int. 2020;4(1):1140.DOI: 10.25107/2638-4558.1140
Eosinophilic Gastroenteritis Complicating Perforation in a Hepatitis C Patient Treated with Direct-Acting Antivirals
Ming X Huang, Chun N Li, Ruo M Ke, Zuo Q Zhang, Zhe Zhu and Xiao M Peng
Department of Infectious Diseases, Sun Yat-Sen University, China Department of Radiology, Sun Yat-Sen University, China Department of Medicine, University of California, USA Central Laboratory, Sun Yat-Sen University, China
*Correspondance to: Xiao M Peng
PDF Full Text Case Study | Open Access
Abstract:
The Direct-Acting Antiviral (DAA) therapy of Hepatitis C Virus (HCV) infection has demonstrated excellent efficacy and safety profile. Based on large cohort studies, Serious Adverse Events (SAEs) are rare [1,2]. Here, we reported the first case of a patient with alcoholic liver cirrhosis super infected by HCV presenting with a SAE of Eosinophilic Gastro Enteritis (EGE) complicating acute perforation during daclatasvir plus sofosbuvir therapy
Keywords:
CT: Computed Tomography; DAA: Direct-Acting Antiviral; EGE: Eosinophilic Gastro Enteritis; HCV: Hepatitis C Virus; SAE: Serious Adverse Event
Cite the Article:
Huang MX, Li CN, Ke RM, Zhang ZQ, Zhu Z, Peng XM. Eosinophilic Gastroenteritis Complicating Perforation in a Hepatitis C Patient Treated with Direct-Acting Antivirals. Clin Case Rep Int. 2020; 4: 1140.